Insilico's AI drug hits Phase 3, and China is the reason
The first AI-discovered drug to reach late-stage trials is being tested in China, where regulators moved faster than the FDA.
By Abdullah Al-Otaibi·· 3 min
Loading the Newsroom
Curating from trusted global sources…